Treatment of Metastatic Malignant Melanoma with Dacarbazine plus Tamoxifen
Authors:
- Mariangela BellaMBMariangela Bella
- Federico CalabresiFCFederico Calabresi
- Maurizio TonatoMTMaurizio Tonato
- Rodolfo CanalettiRCRodolfo Canaletti
- Corrado BoniCBCorrado Boni
- Franco BuzziFBFranco Buzzi
- Guido CeciGCGuido Ceci
- Enrichetta CorgnaECEnrichetta Corgna
- Paolo CostaPCPaolo Costa
- Renata LotticiRLRenata Lottici
- Franco PapadiaFPFranco Papadia
- 20 August 1992
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 327 (8) , 516-523
Abstract
Endocrine factors may affect the clinical course of malignant melanoma and the response to the treatment of this disease. The presence of estrogen receptors in melanomas has been suggested, and occasional responses to antiestrogen therapy have been reported.Keywords
This publication has 39 references indexed in Scilit:
- Cellular Immune Response Against Autologous Human Malignant Melanoma: Are In Vitro Studies Providing a Framework for a More Effective Immunotherapy?JNCI: Journal of the National Cancer Institute, 1990
- The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanomaCancer, 1989
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.Journal of Experimental Medicine, 1986
- Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifenEuropean Journal of Cancer and Clinical Oncology, 1985
- In vitro stimulation of human NK activity by an estrogen antagonist (tamoxifen)European Journal of Cancer and Clinical Oncology, 1984
- Estrogen receptor in malignant melanoma: Fact or artefact?European Journal of Cancer and Clinical Oncology, 1983
- Aromatization of steroids in peripheral tissuesJournal of Steroid Biochemistry, 1983
- Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures.Journal of Experimental Medicine, 1981
- Changes of the immunogenic properties of K36 lymphoma treated in vivo with 5(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC)1979
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958